Skip to content

13F-HR filed by Avidity Partners Management LP

Avidity Partners Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 22:01:48 UTC, with 18 holding rows worth $488,204,016.

Accession
0001791827-26-000008
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 18 entries on the cover page, a total value of $488,204,016 stated on the cover page (in dollars after the unit check, H1), rows summing to $488,204,016 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DIANTHUS THERAPEUTICS INC252828108COM1,899,593$167,259,164dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK1,348,948$95,626,924dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock785,424$65,417,965dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK850,000$60,256,500dollars as filedcall
JADE BIOSCIENCES INC008064206COM NEW2,000,000$28,100,000dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock550,000$25,212,000dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V302COMMON STOCK6,067,999$16,686,997dollars as filed
AKTIS ONCOLOGY INC01021M104COMMON STOCK484,200$9,427,374dollars as filed
IMMUNIC INC4525EP200COM NEW669,941$6,230,451dollars as filed
MOBIA MED INC60705V103COMMON STOCK324,676$3,068,188dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK20,000$2,758,600dollars as filed
NUVECTIS PHARMA INC67080T108COMMON STOCK100,415$2,120,765dollars as filed
SATELLOS BIOSCIENCE INC80401L803COM164,019$1,394,162dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM4,060,254$1,219,700dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK884,900$1,079,578dollars as filed
SENSEONICS HOLDINGS INC81727U303COMMON STOCK100,000$1,017,000dollars as filed
SCYNEXIS INC811292309COM153,613$758,848dollars as filed
AVALYN PHARMA INC05348Y105COMMON STOCK20,000$569,800dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001791827-26-000008this filing2026-11-16